Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-03-11

FDA Approved: ZALEPLON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zaleplon from Hikma Pharmaceuticals USA Inc., typically affecting the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

SUPPL AP for ZALEPLON (ZALEPLON)